MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

Abstract excerpt

// Jen-Chieh Lee 1 , 2 , * , Shu Liu 1 , * , Yucheng Wang 1 , * , You Liang 1 and David M. Jablons 1 1 Thoracic Oncology, Department of Medicine, University of California, San Francisco, CA 94143, USA 2 Touro University, College of Osteopathic Medicine, Vallejo, CA 94592, USA * These authors contributed equally to this work Correspondence to: Jen-Chieh Lee, email: jenchieh.lee@ucsf.edu Shu Liu, email:...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Cancer-related Molecular Pathways
• Share to Cytokine Signaling Pathways and Interactions